Preeclamptic plasma stimulates the expression of miRNAs, leading to a decrease in endothelin-1 production in...

Area of Science:

• Obstetrics and Gynecology
• Molecular Biology
• Cardiovascular Research

Background:

• Preeclampsia is a significant cause of maternal and fetal mortality globally.
• It's characterized by endothelial dysfunction, with endothelin-1 (ET-1) implicated in its pathophysiology.
• Targeting the ET-1 gene (EDN1) with microRNAs (miRNAs) is a potential therapeutic avenue.

Purpose of the Study:

• To investigate the relationship between miRNAs targeting EDN1 and ET-1 levels in preeclampsia.
• To determine if plasma from preeclamptic women affects miRNA expression in HUVECs.
• To explore the therapeutic potential of miRNAs in managing preeclampsia.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs) were incubated with plasma from preeclamptic and healthy pregnant women.
• Expression levels of EDN1, ET-1, and specific miRNAs (let-7 family, miR-125) were analyzed.
• HUVECs were transfected with mimic miRNA let-7 to assess its effect on ET-1 levels.

Main Results:

• EDN1 expression and ET-1 levels were similar in HUVECs incubated with plasma from both groups.
• Expression of let-7a, -7b, -7c, and miR-125a, -125b was elevated in HUVECs exposed to preeclamptic plasma.
• let-7 family miRNA expression negatively correlated with ET-1 levels in preeclampsia.
• Transfection with mimic miRNA let-7 reduced ET-1 levels in preeclamptic cultures.

Conclusions:

• Preeclamptic plasma stimulates miRNA expression in HUVECs.
• This miRNA upregulation leads to decreased ET-1 levels.
• Therapeutic miRNAs show promise for preeclampsia management.